These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38677160)

  • 1. Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis.
    Santo T; Gisev N; Campbell G; Colledge-Frisby S; Wilson J; Tran LT; Lynch M; Martino-Burke D; Taylor S; Degenhardt L
    Int J Drug Policy; 2024 Jun; 128():104434. PubMed ID: 38677160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis.
    Santo T; Campbell G; Gisev N; Martino-Burke D; Wilson J; Colledge-Frisby S; Clark B; Tran LT; Degenhardt L
    Drug Alcohol Depend; 2022 Sep; 238():109551. PubMed ID: 35797876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis.
    Santo T; Campbell G; Gisev N; Tran LT; Colledge S; Di Tanna GL; Degenhardt L
    Drug Alcohol Depend; 2021 Feb; 219():108459. PubMed ID: 33401031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis.
    Hunt GE; Malhi GS; Cleary M; Lai HM; Sitharthan T
    J Affect Disord; 2016 Dec; 206():331-349. PubMed ID: 27476137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis.
    Hunt GE; Malhi GS; Cleary M; Lai HM; Sitharthan T
    J Affect Disord; 2016 Dec; 206():321-330. PubMed ID: 27426694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
    Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
    J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
    Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
    Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis.
    Devoe DJ; Dimitropoulos G; Anderson A; Bahji A; Flanagan J; Soumbasis A; Patten SB; Lange T; Paslakis G
    J Eat Disord; 2021 Dec; 9(1):161. PubMed ID: 34895358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta-analysis of prevalence and correlates.
    Yang J; Jung M; Picco L; Grist E; Lloyd-Jones M; Giummarra M; Nielsen S
    Addiction; 2024 Nov; 119(11):1879-1901. PubMed ID: 38886901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder.
    Frankeberger J; Coulter RWS; Jarlenski M; Krans EE; Mair C
    Prev Med; 2024 Aug; 185():108057. PubMed ID: 38942123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid analgesic use and its sequelae: Opioid and other substance use disorders.
    Rhee TG; Rosenheck RA
    Early Interv Psychiatry; 2021 Aug; 15(4):975-982. PubMed ID: 32930517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis.
    Baranyi G; Fazel S; Langerfeldt SD; Mundt AP
    Lancet Public Health; 2022 Jun; 7(6):e557-e568. PubMed ID: 35660217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients.
    Liu S; Nwabueze C; Pan Y; Walter SM; Su B; Xu C; Winstanley EL; Wang K
    West J Nurs Res; 2022 Dec; 44(12):1088-1099. PubMed ID: 34301163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse diagnostic profiles associated with prescription opioid use disorder in a nationwide sample: One crisis, multiple needs.
    De Nadai AS; Little TB; McCabe SE; Schepis TS
    J Consult Clin Psychol; 2019 Oct; 87(10):849-858. PubMed ID: 31556662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-occurring substance use and mental disorders among adults with opioid use disorder.
    Jones CM; McCance-Katz EF
    Drug Alcohol Depend; 2019 Apr; 197():78-82. PubMed ID: 30784952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.